FB

ARE YOU READY TO SAY, “NOT ME, RSV!”?

Respiratory Syncytial Virus, or RSV, is just one of the many viral risks we are now facing as a society, and infection rates are at an all-time high with no sign of slowing down any time soon. DM Clinical is currently evaluating potential preventative options for children, adults, and elderly adults.

WHAT IS RSV?

RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, however, RSV can be dangerous for certain elderly adults or young children. Severe RSV infections can also lead to serious conditions such as Pneumonia or Bronchitis.

Symptoms:

  • Congested or runny nose
  • Dry cough
  • Low-grade fever
  • Sore throat
  • Sneezing
  • Headache

People infected with RSV can spread the virus for 3 to 8 days. However, some infants and people with weakened immune systems can spread the virus for up to 4 weeks.

rsv-image

177,000 older adults are hospitalized from RSV each year. Of those, 14,000 will pass away.

58,000 children under age 5 are hospitalized from RSV each year. Of those, 500 will pass away.

Don’t let you or your child become another statistic! It’s time to say “NOT ME, RSV!”, enroll in preventative research today!

ABOUT THE STUDIES

We have preventative vaccine studies for children aged 0-4 years old, adults aged 18-49 years old, and elderly adults aged 60 years or older. Those who qualify and choose to participate in the studies could have access to the preventative study vaccines and direct oversight from the DM Clinical medical team and board-certified physicians at no cost. No insurance information is taken or needed to participate in the studies. Reimbursement for study-related time and travel is also available for qualified participants. The compensation varies depending on the study but could be up to $800.

RSV-Current-Studies

WHAT TO EXPECT FROM YOUR RESEARCH JOURNEY

The first thing you can expect when you sign up for a clinical trial with DM Clinical Research is an initial phone call from one of our trained patient enrollment specialists. Here, we will confirm your interest in the study and ask you specific questions to see if you would be a good potential fit for the study.

Once it’s determined that you could be a good potential fit for the study, we will schedule you an in-person screening visit. Here, you will meet some of the study team and have the chance to ask any questions you may have about the informed consent process. This is where we will also do testing specific to your studies such as blood work, x-rays, MRIs, or diagnosis questionnaires.

RSV-Section2

From there, the process varies depending on your study, but once it is determined that you fully qualify for the study, you will be scheduled for your first study visit and follow a visit schedule specific to your study. Depending on your study, you will likely be randomly assigned to receive either the study medication or a placebo. You may choose to quit the study and withdraw your consent at any time.

ABOUT DM CLINICAL

DM Clinical Research has been helping to bring new treatments to the medical field for over 15 years. DM Clinical is the link connecting pharmaceutical and research organizations to caring individuals who want to play a part in the advancement of medicine. DM Clinical has a large network of qualified physicians with a diverse range of specialties. DM Clinical Research has conducted hundreds of studies in a wide variety of therapeutic areas in which many patients have seen improvements in their symptoms.
RSV-About-DM-Clinical-Research

DM Clinical

Advancing medicine through innovation and dedication.